Ariel Investments, LLC

Institutional investor · Portfolio as of Q2 2026

Top Holdings106 positions

Checking export access…
Activity:
MSGE

Madison Square Garden Entertainment Corp.

5.3M$428.9M4.3%$34.02+131.82%
13 qtrssince 2023-Q2
Decreased
0
OSW

OneSpaWorld Holdings Limited

14.9M$420.4M4.2%$13.54+137.88%
26 qtrssince 2020-Q1
Decreased
0
CRL

Charles River Laboratories International, Inc.

1.5M$341.6M3.4%$187.18+84.74%
30 qtrssince 2019-Q1
Increased
59
AMG

Affiliated Managers Group, Inc.

999,676$338.3M3.4%$116.76+243.70%
30 qtrssince 2019-Q1
Decreased
0
JLL

Jones Lang LaSalle Incorporated

1.1M$328.6M3.3%$178.21+110.07%
30 qtrssince 2019-Q1
Increased
59
NCLH

Norwegian Cruise Line Holdings Ltd.

15.4M$325.7M3.2%$18.95-2.34%
26 qtrssince 2020-Q1
Increased
60
GNRC

Generac Holdlings Inc.

997,951$292.2M2.9%$123.24+47.51%
17 qtrssince 2022-Q2
Decreased
0
SPHR

Sphere Entertainment Co.

1.7M$288.2M2.9%——
25 qtrssince 2020-Q2
Decreased
0
MIDD

The Middleby Corporation

1.6M$282.8M2.8%$108.41+27.54%
26 qtrssince 2020-Q1
Increased
55
MSGS

MADISON SQUARE GRDN SPRT COR

658,551$264.6M2.6%$177.25+123.47%as of Oct 16
30 qtrssince 2019-Q1
Decreased
0
NVST

Envista Holdings Corporation

9.8M$258.7M2.6%$20.56+25.71%
26 qtrssince 2020-Q1
Decreased
0
ZBRA

Zebra Technologies Corporation

922,998$243M2.4%——
30 qtrssince 2019-Q1
Increased
62
LAZ

Lazard, Inc.

5.8M$241.4M2.4%$37.91+8.27%
10 qtrssince 2024-Q1
Decreased
0
BIO

Bio-Rad Laboratories, Inc.

816,751$239.8M2.4%$301.46+28.20%
30 qtrssince 2019-Q1
Increased
55
PBH

Prestige Consumer Healthcare Inc.

4.9M$230.1M2.3%$58.65-23.32%
17 qtrssince 2022-Q2
Increased
60
BOKF

BOK Financial Corporation

1.6M$226M2.3%$62.88+108.66%
30 qtrssince 2019-Q1
Decreased
0
FAF

First American Financial Corporation

3.2M$221.5M2.2%$45.59+48.34%
30 qtrssince 2019-Q1
Decreased
0
ATGE

COVISTA INC

1.8M$220.9M2.2%$57.95+101.05%
30 qtrssince 2019-Q1
Decreased
0
MAT

Mattel, Inc.

15.4M$214M2.1%$13.88+15.24%
30 qtrssince 2019-Q1
Increased
60
MHK

Mohawk Industries, Inc.

1.8M$213.1M2.1%$118.16+28.41%
30 qtrssince 2019-Q1
Increased
53
$10B
AUM
106
Positions
Q2 2026
Filing
HI rating · 3.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2025-Q1$8,509,613,093-9.19703469155%
2025-Q2$8,822,290,0873.67439730318%
2025-Q3$9,350,361,1645.98564626409%
2025-Q4$9,258,581,319-0.981564705258%
2026-Q1$8,934,260,435-3.50292202256%
2026-Q2$10,029,168,54212.2551621924%
Activity profile
$ moved · Q2'26
New15%Increased45%Decreased34%Exited5%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 4.7 years
<1Q4%1-4Q12%1-2Y5%2Y+79%

Ariel Investments, LLC manages $10B across 106 positions as of Q2 2026. Top holdings: MSGE (4.3%), OSW (4.2%), CRL (3.4%). Fund DNA: Steady Compounder. HoldingsIntel Score: 3/5.0.

Q2 2026 Summary

Active quarter - 8 new positions, 8 exits, 33 increased. Top move: ZBRA (INCREASED, conviction 62). Portfolio: $10.0B across 106 positions.

Top holdings by portfolio weight

Total AUM$10B
MSGE4.28%
OSW4.19%
CRL3.41%
AMG3.37%
JLL3.28%
NCLH3.25%
GNRC2.91%
SPHR2.87%
MIDD2.82%
MSGS2.64%
Other2.58%

Portfolio allocation by GICS sector

Sectors11
Consumer Cyclical21.70%
Financial Services19.31%
Healthcare15.54%
Industrials12.27%
Communication Services9.50%
Technology7.24%
Consumer Defensive4.33%
Real Estate3.74%
Basic Materials2.45%
Energy2.29%
Other1.63%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Consumer Cyclical, Financial Services, Healthcare
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L69
Conviction55
Concentration50
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
7Q
FISVFISVFiserv, Inc.
Q4 2024 → Q2 2026+540,574 shares+$25.9M
7Q
KSPIKSPIJoint Stock Company Kaspi.kz
Q4 2024 → Q2 2026+21,404 shares+$1.8M
4Q
MIDDMIDDThe Middleby Corporation
Q3 2025 → Q2 2026+709,399 shares+$148.2M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used